Create issue ticket

385 Possible Causes for Anti CEA, Y90, Yttrium, antibody, monoclonal

Did you mean: Anti CEA, Y90, Yttrium, antimony, monoclonal

  • Iodine-131-Tositumomab

    […] infusion occur in small numbers of patients (2% grade 3/4 reactions following I 131 tositumomab, and more frequently occurring during the rituximab infusion at the time of Y90[] Several other murine anti-CEA RIT agents have been evaluated, including 131 I-NP-4 F(ab′) 2 , 131 I-F6 F(ab′) 2 , 131 I-A5B7, 131 I-COL-1, and 186 Re-NR-CO-02 F(ab′) 2 [ 50[] MeSH terms Adult Antibodies, Monoclonal/adverse effects Antibodies, Monoclonal/pharmacokinetics Antibodies, Monoclonal/therapeutic use* Antineoplastic Combined Chemotherapy[] Abstract Iodine-131 tositumomab [B1, Bexxar , iodine-131 anti-B1 antibody] is a murine antibody conjugated to iodine 131 that recognises and binds to the B1 (CD20) antigen[] It is the second radioimmunoconjugate to be approved for refractory NHL; yttrium-90 linked to ibritumomab tiuxetan (Zevalin) was approved in 2002.[]

  • Follicular Lymphoma

    You get this medication -- Y90 ibritumomab tiuxetan (Zevalin) -- through an IV. It delivers radiation straight to a protein on cancer cells.[] Compared to previous reports, we used a more sensitive FCI method by combining both monoclonal and polyclonal anti-LC antibodies.[] The antibody is trademarked Rituxan in the U.S., Japan, and Canada.[] Abstract Yttrium 90 ((90)Y) ibritumomab tiuxetan (Zevalin), a radiolabeled monoclonal antibody against the CD20 antigen, is indicated for the treatment of patients with relapsed[] PURPOSE: We conducted an international, randomized, phase III trial to evaluate the efficacy and safety of consolidation with yttrium-90 ((90)Y)-ibritumomab tiuxetan in patients[]

    Missing: Anti CEA
  • Daclizumab

    ., Intramural MeSH terms Adult Aged Antibodies, Monoclonal, Humanized/chemistry Antibodies, Monoclonal, Humanized/immunology Antibodies, Monoclonal, Humanized/therapeutic[] Gov't MeSH terms Antibodies, Monoclonal/chemistry* Antibodies, Monoclonal/therapeutic use Antibodies, Monoclonal, Humanized Basiliximab Binding Sites Complementarity Determining[] […] [email protected] Abstract Following the recent approval of the first oral therapy for multiple sclerosis (MS), fingolimod, multiple other oral compounds, and also a number of monoclonal[] One fusion antibody links the antibody with radioactive yttrium (Y 90), effectively bringing radiation therapy directly to the cancer cells.[] […] case series of young Stevens-Johnson syndrome (SJS) patients with cicatrizing ocular surface disease and recurrent inflammation (SJS-RI) treated with systemic humanized monoclonal[]

    Missing: Anti CEA Y90
  • Cold Agglutinin Disease

    HBc IgG Anti HBs Ag HBe Anti HBe Anti HIV CMV IgM CMV IgG TOXO IgM TOXO IgG EBV IgM EBV IgG HTLV SIFILIS Cortisol Markeri Tumorali AFP CEA CA 19 – 9 CA 15 – 3 CA 125 PSA[] CONCLUSIONS: Monoclonal IgM lambda anti-Pr is a rarely found cold agglutinin antibody.[] […] complications* Lupus Erythematosus, Systemic/drug therapy Lupus Erythematosus, Systemic/immunology Middle Aged Rituximab Substances Antibodies, Monoclonal Antibodies, Monoclonal[] We performed a small, open, uncontrolled, prospective study to evaluate the effect of therapy with the monoclonal anti-CD20 antibody rituximab.[] Stratton , ERYTHROCYTE ANTIBODIES AND AUTOIMMUNITY , The Lancet , 282 , 7308 , (626) , (1963) . M. ADINOLFI, CHRISTINE DANIELS and P. L.[]

    Missing: Y90 Yttrium
  • Trastuzumab

    Anticorps anti-cea de classe i et leurs utilisations WO2011130580A1 ( fr ) 2010-04-15 2011-10-20 Alper Biotech, Llc Anticorps monoclonaux contre antigènes her2 et leurs utilisations[] The essential role of HER2 in the HER signaling network led to the development of anti-HER2 monoclonal antibodies (MAbs) for cancer therapy.[] A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 1997; 14:2099–2109.[] Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961. ‎[] BACKGROUND: Antibody-drug conjugates have emerged as a powerful strategy in cancer therapy and combine the ability of monoclonal antibodies to specifically target tumour cells[]

    Missing: Y90 Yttrium
  • Liver Metastasis

    KEYWORDS: Y90; biomarkers; colorectal cancer; liver cancer; radioembolization[] On day 9, 90 Y-cT84.66 anti-CEA at 16.6 mCi/m 2 as an i.v. bolus infusion and on days 9-11 i.v. gemcitabine at 105 mg/m 2 were given.[] Immunotherapy with monoclonal antibodies tagged with cytotoxic agents. Gene therapy with retroviral vectors containing genes expressing cytotoxic agents.[] We explored the association between liver metastases, tumor CD8 T-cell count, and response in patients with melanoma or lung cancer treated with the anti-PD-1 antibody, pembrolizumab[] 0325 Abstract We explored the association between liver metastases, tumor CD8 T cell count, and response in patients with melanoma or lung cancer treated with the anti-PD-1 antibody[]

  • Adult T-Cell Leukemia - Lymphoma

    , Monoclonal, Humanized/adverse effects* Bronchiolitis/chemically induced* Female Haemophilus Infections/chemically induced* Humans Hypoxia Leukemia-Lymphoma, Adult T-Cell[] Gov't MeSH terms Adult Antibodies, Monoclonal/immunology* Antibodies, Monoclonal/pharmacology Antigens, CD/genetics Antigens, CD/immunology* Cell Line, Tumor Cell Proliferation[] Yttrium Y 90-ibritumomab tiuxetan is an example of a radiolabeled monoclonal antibody. Monoclonal antibodies are given by infusion.[] A new anti-CC chemokine receptor 4 monoclonal antibody (mogamulizumab) has been shown to be effective for ATLL.[] T-cell lymphoma with typical morphologic and immunophenotypic features of AITL could be confidently diagnosed as AITL even if the patient was seropositive for anti-HTLV antibody[]

    Missing: Anti CEA Y90
  • Waldenstrom Macroglobulinemia

    IgM monoclonal gammopathy of undetermined significance (IgM MGUS) and Waldenström macroglobulinemia (WM) are sometimes clinically difficult to distinguish.[] ; and (3) binding of this circulating IgM-kappa antiepidermal basement membrane zone antibody to both sides of 1 mol/L sodium chloride split skin.[] . : Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory lowgrade[] Two monoclonal Igs (whole IgG1/kappa and IgG1/kappa half molecules) occurred in the serum in addition to the IgM monoclonal protein.[] Treating Patients With Multiple Myeloma or Other B-cell Cancers Unknown status NCT00003163 Phase 2 cyclophosphamide;melphalan 48 Rituximab, Fludarabine, Cyclophosphamide, and Yttrium[]

    Missing: Anti CEA Y90
  • Chelating Agent

    Conjugation with mAbs [(anti-carcinoembryonic antigen (CEA) and anti-epidermal growth factor receptor (EGFr)] was performed at pH 8.4 using trisodium phosphate solution by[] BACKGROUND: The development of new bifunctional chelating agents for the labeling of monoclonal antibodies with radiometals is a desirable goal in the area of radioimmunodetection[] Abstract Yttrium-90 (90Y) is a promising radiometal for therapy of cancer due to its high-energy beta emission and a physical half-life of 2.67 days.[] Using LiLo, indium-111 was conjugated to a human monoclonal antibody, 16.88.[] Following administration of 67Ga-labeled F(ab')2 fragment, kidney accumulation was higher than with the intact antibody (29% and 4% ID/g, respectively) and blood levels lower[]

    Missing: Y90
  • Insulin Receptor Antibody

    Albumina Aldosterona Alpha-MSH AMP cíclico Androstane Diol Glucoronido Androstenediona I-125 Androstenodina Angiotensina ANP Anticuerpos anti-Insulina Anti-Tiroglobulina Anti-TPO[] Host: Mouse Clonality: Monoclonal Purification: Protein G purified Immunogen: Human placental one (1) year at -20C to -70C. insulin receptor.[] Insulin antibodies were present in high titre. Most of the insulin in serum was bound to the insulin antibodies and free insulin was slightly increased.[] Biochemical Journal Jun 15, 1990, 268 (3) 615-620; DOI: 10.1042/bj2680615 Abstract The effects of insulin and anti-(insulin receptor) monoclonal antibodies on tyrosine phosphorylation[] Background: XOMA 358 (X358) is a fully human monoclonal antibody to the insulin receptor that acts as a negative allosteric modulator of insulin signaling.[]

    Missing: Y90 Yttrium